Tuesday, December 2, 2008 - 3:44PM EST

Drug Therapy

1. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.

Author
Dello Russo NM; Jeffcoat MK; Marx RE; Fugazzotto P;
Institution
Journal
Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):146-53.

2. Use of intravenous bisphosphonates in osteoporosis.

Author
Civitelli R; Napoli N; Armamento-Villareal R;
Institution
Division of Bone and Mineral Diseases, Washington University in St. Louis, 660 S. Euclid Avenue, St. Louis, MO 63110, USA. rcivitel@im.wustl.edu
Journal
Curr Osteoporos Rep. 2007 Mar;5(1):8-13.
Abstract URL
Click here to view abstract

3. Adherence to medications for the treatment of osteoporosis.

Author
Silverman S;
Institution
Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center/UCLA, The Osteoporosis Medical Center, 8641 Wilshire Boulevard, Suite 301, Beverly Hills, CA 90211, USA. stuarts@omcresearch.org
Journal
Rheum Dis Clin North Am. 2006 Nov;32(4):721-31.
Abstract URL
Click here to view abstract

4. Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.

Author
Morris GJ; Mitchell EP;
Institution
Kimmel Cancer Center, Thomas Jefferson University Hospital, 111 S. 11th St., Suite 4240, Gibbon Building, Philadelphia, PA 19107, USA. Gloria.Morris@jefferson.edu
Journal
J Natl Med Assoc. 2007 Jan;99(1):35-45.
Abstract URL
Click here to view abstract

5. Strontium ranelate: a novel treatment in postmenopausal osteoporosis.

Author
Tournis S; Economopoulos D; Lyritis GP;
Institution
Laboratory for Research of Musculoskeletal System Th. Garofalidis, University of Athens, KAT Hospital, 10 Athinas Str., Kifissia, PC: 14561, Athens, Greece. stournis@med.uoa.gr
Journal
Ann N Y Acad Sci. 2006 Dec;1092:403-7.
Abstract URL
Click here to view abstract

6. The teriparatide in the treatment of severe senile osteoporosis.

Author
Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D;
Institution
Dipartimento di Scienze della Senescenza, Urologiche e Neurourologiche, Universita degli Studi di Catania, Ospedale Cannizzaro, Via Messina 829, I-95126 Catania, Italy.
Journal
Arch Gerontol Geriatr. 2007;44 Suppl 1:249-58.
Abstract URL
Click here to view abstract

7. Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?

Author
Gold DT; Silverman SL;
Institution
Department of Psychiatry, Center for the Study of Aging and Human Development, Box 3003, Duke University Medical Center, Durham, NC 27710, USA. dtg@geri.duke.edu
Journal
Curr Osteoporos Rep. 2007 Mar;5(1):3-7.
Abstract URL
Click here to view abstract

8. Bisphosphonates: mode of action and pharmacology.

Author
Russell RG;
Institution
Botnar Research Centre, Oxford University Institute of Musculoskeletal Sciences, Oxford, United Kingdom. graham.russell@ndos.ox.ac.uk
Journal
Pediatrics. 2007 Mar;119 Suppl 2:S150-62.
Abstract URL
Click here to view abstract

9. Subtrochanteric insufficiency fractures in patients on alendronate therapy: A CAUTION.

Author
Goh SK; Yang KY; Koh JS; Wong MK; Chua SY; Chua DT; Howe TS;
Institution
1Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, Singapore, 169608, Republic of Singapore.
Journal
J Bone Joint Surg Br. 2007 Mar;89(3):349-53.
Abstract URL
Click here to view abstract

10. Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density.

Author
Napoli N; Thompson J; Civitelli R; Armamento-Villareal RC;
Institution
Division of Bone and Mineral Diseases, Washington University School of Medicine, St Louis, MO 63110, USA.
Journal
Am J Clin Nutr. 2007 May;85(5):1428-33.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7